Janus Henderson Group PLC reduced its holdings in shares of Clarivate Plc (NYSE:CLVT - Free Report) by 4.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,978,592 shares of the company's stock after selling 587,147 shares during the period. Janus Henderson Group PLC owned 1.69% of Clarivate worth $60,854,000 at the end of the most recent reporting period.
Other hedge funds have also bought and sold shares of the company. Clarkston Capital Partners LLC increased its position in shares of Clarivate by 8.1% during the fourth quarter. Clarkston Capital Partners LLC now owns 70,733,831 shares of the company's stock valued at $359,328,000 after acquiring an additional 5,319,535 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of Clarivate by 53.6% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 27,776,892 shares of the company's stock worth $141,107,000 after purchasing an additional 9,691,104 shares in the last quarter. Thompson Siegel & Walmsley LLC raised its stake in shares of Clarivate by 14.4% in the fourth quarter. Thompson Siegel & Walmsley LLC now owns 10,498,588 shares of the company's stock worth $53,333,000 after purchasing an additional 1,323,329 shares during the last quarter. Perpetual Ltd lifted its holdings in shares of Clarivate by 24.6% during the fourth quarter. Perpetual Ltd now owns 9,192,680 shares of the company's stock valued at $46,699,000 after purchasing an additional 1,816,936 shares in the last quarter. Finally, Vanguard Group Inc. boosted its position in shares of Clarivate by 6.6% during the fourth quarter. Vanguard Group Inc. now owns 8,750,858 shares of the company's stock valued at $44,454,000 after buying an additional 538,907 shares during the last quarter. Institutional investors own 85.72% of the company's stock.
Analyst Ratings Changes
Separately, Royal Bank of Canada reiterated a "sector perform" rating and issued a $6.00 price target on shares of Clarivate in a research note on Thursday, February 20th.
Get Our Latest Stock Report on Clarivate
Clarivate Stock Performance
CLVT traded up $0.01 during trading on Monday, hitting $4.31. The company's stock had a trading volume of 402,890 shares, compared to its average volume of 5,234,693. The business's 50 day simple moving average is $3.88 and its 200-day simple moving average is $4.67. The firm has a market cap of $2.94 billion, a PE ratio of -4.47 and a beta of 1.49. Clarivate Plc has a one year low of $3.04 and a one year high of $7.15. The company has a quick ratio of 0.88, a current ratio of 0.87 and a debt-to-equity ratio of 0.88.
Clarivate (NYSE:CLVT - Get Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The company reported $0.14 EPS for the quarter, topping analysts' consensus estimates of $0.12 by $0.02. The business had revenue of $593.70 million during the quarter, compared to analysts' expectations of $574.03 million. Clarivate had a positive return on equity of 9.10% and a negative net margin of 24.90%. The business's quarterly revenue was down 4.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.14 earnings per share. As a group, sell-side analysts predict that Clarivate Plc will post 0.63 EPS for the current fiscal year.
Clarivate Company Profile
(
Free Report)
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Read More

Before you consider Clarivate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clarivate wasn't on the list.
While Clarivate currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.